Top news of the day from across the healthcare landscape.
A major investor in Theranos is now alleging that the company and CEO Elizabeth Holmes used deception to obtain a $100 million investment. The company, Partner Fund Management LP, said that Holmes and other executives claimed it had created technology that worked, and was close to receiving approval, according to The Wall Street Journal. However, Theranos is assuring their investors and the public that the allegations in lawsuit are not true.
Findings from a new report show that pediatric cancer mortality rates have been declining across all races and ages, dropping 20% from 1999 to 2014. Adolescents (15- to 19-years-old) were the most likely to die from cancer, but their mortality rate fell 22% during this time. Mortality rates did not differ among whites and blacks, but it was 30% higher for boys compared with girls, The New York Times reported.
With a focus on having the latest, cutting-edge technology, health diagnostic applications and websites have become increasingly popular. However, these new technologies are still not as accurate as seeing a physician for the issue. A recent head-to-head comparison showed that physicians outperformed 23 symptom-checker technologies by a margin of more than 2 to 1, according to the Los Angeles Times.